While the path to economic recovery certainly requires tireless work and focused attention over the long-term, there are efforts that are accelerating recovery in our region right now. Through Recharge & Recover PHL, the Chamber has continued our activities to promote Greater Philadelphia as a hub for cell and gene therapy in order to attract companies, capital, and talent to our region.
Future-Proofing Life Science Talent
The life science sector continues to be a bright spot for Greater Philadelphia despite the setbacks faced by other industries during the pandemic. Demand for lab space is on the rise and the sector represents more than 800 companies and 56,000 employees in the region, according to a recent Philadelphia Business Journal article. The Chamber’s CEO Council for Growth, along with University City Science Center and University City District’s West Philadelphia Skills Initiative, commissioned the 2020 Cell and Gene Therapy and Connected Health Talent Needs Assessment, an independent study conducted by Econsult Solutions, Inc. Among other findings, the assessment estimated that over the next 10 years our region’s cell and gene therapy workforce is projected to grow between 35% and 94% using mid-range estimates. High-end estimates could see the sector adding over 11,000 jobs to the region over the next decade.
All this is to say, our region is soon going to be in need of thousands of workers prepared to take on highly-skilled roles in the cell and gene therapy sector.
Launched last fall, the Chamber’s employer-driven Life Science Talent Pipeline Collaborative is working to proactively address our region’s life science workforce needs. Through data-driven analysis, the group of 19 organizations has identified jobs critical to the future of the industry and are working collaboratively to identify and action solutions.
To that end, the Life Science Talent Pipeline Collaborative will also be making connections with existing and emerging programs that support workforce development in the sector. This includes partnerships like the one kicked-off last month between The Wistar Institute and Cheyney University of Pennsylvania to give students first-hand experience in biomedical sciences. The students will be exposed to topics in molecular biology, cancer biology, innovative research, laboratory skills, and the courses have the potential to lead to internships that could progress into Wistar’s credentialed apprenticeship program.
The 19 collaborative members, along with key partners like initiative funder Philadelphia Works, are now focused on the next steps of identifying and organizing opportunities for training in the critical roles outlined above.
Attracting Life Science to Our Region
Over the last few years, we have seen life science companies like Amicus Therapeutics and Iovance Biotherapeutics Inc. choose to locate new bases of operations in Greater Philadelphia. The sector has also seen significant acquisition and expansion events in recent years from cell and gene therapy companies already established in the region, like the acquisition of Spark Therapeutics, Inc. by the Swiss-based pharmaceutical company Roche. And we’re seeing commercial real estate markets respond to the demand for lab space described above with the development of new state-of-the-art facilities like the recent expansion of WuXi Advanced Therapies’ Philadelphia campus to increase regional testing capabilities. The momentum of these recent events has created an energy of possibility in Greater Philadelphia’s life science sector.
The Chamber’s Select Greater Philadelphia Council (Select) has been capitalizing on this momentum and energy to continue building awareness about our region’s cell and gene therapy assets both nationally and globally so our region has more stories like these to tell in the future.
Through social media advertising, account-based marketing, and virtual meetings and events, Select is identifying likely candidates in the cell and gene therapy space for relocation to or expansion in our region. Once we have identified a potential locate through our marketing efforts, we are able to offer our advisory and collaborative services, connecting them with key leaders and resources, and acting as a dedicated partner throughout the process.
From targeted digital marketing to our advisory and collaborative services, we are actively identifying and nurturing relationships with potential newcomers with the goal of bringing new life science investment to our region.
By scaling and future-proofing our region’s skilled life science workforce and inviting new companies to join the thriving cell and gene therapy ecosystem today, we will position Greater Philadelphia to emerge from the pandemic with a brighter tomorrow.
Making Greater Philadelphia a global cell and gene therapy hub is an aspiration of the Recharge & Recover PHL initiative. Join regional leaders as we prioritize regional health and safety, create opportunities for displaced workers, and bolster support for Black, brown, and local businesses in a shared effort to stabilize, energize, and prepare Greater Philadelphia for a durable recovery.